
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.410 | 87.650 | 86.240 |
Shares | 97.740 | 97.780 | 0.040 |
Bonds | 0.030 | 0.030 | 0.000 |
Other | 0.820 | 0.820 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.836 | 19.947 |
Price to Book | 3.196 | 3.928 |
Price to Sales | 1.621 | 2.274 |
Price to Cash Flow | 12.612 | 15.466 |
Dividend Yield | 2.651 | 1.431 |
5 Years Earnings Growth | 9.917 | 11.126 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 49.670 | 94.454 |
Financial Services | 23.390 | 7.589 |
Consumer Cyclical | 15.090 | 6.659 |
Consumer Defensive | 4.680 | 3.238 |
Real Estate | 2.880 | 1.184 |
Technology | 2.580 | 4.070 |
Industrials | 1.720 | 2.789 |
Number of long holdings: 159
Number of short holdings: 102
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Allianz | DE0008404005 | 3.14 | 355.30 | +0.40% | |
Sun Life Financial | CA8667961053 | 3.02 | 89.38 | +0.31% | |
MetLife | US59156R1086 | 2.82 | 79.93 | +1.74% | |
Eli Lilly | US5324571083 | 2.74 | 769.88 | +0.55% | |
SCI | US8175651046 | 2.71 | 79.24 | +1.29% | |
BlackRock | US09290D1019 | 2.69 | 989.05 | +0.36% | |
Boston Scientific | US1011371077 | 2.69 | 102.09 | -0.72% | |
Legal & General | GB0005603997 | 2.63 | 256.10 | -0.70% | |
Apple | US0378331005 | 2.52 | 203.92 | +1.64% | |
Novo Nordisk B | DK0062498333 | 2.49 | 490.4 | +2.87% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1530899142 | 3.28B | -16.96 | 2.15 | - | ||
LU2035461495 | 3.28B | -16.82 | 2.44 | - | ||
LU1903290036 | 3.28B | -5.76 | 7.48 | - | ||
LU1530900684 | 3.28B | -16.72 | 3.17 | - | ||
LU1902444402 | 1.81B | -3.44 | 6.51 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review